Tesamorelin

Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH) that has been studied for its ability to stimulate endogenous growth hormone secretion. Originally developed and approved for reducing visceral adipose tissue in select clinical populations, it is now being explored in both preclinical and clinical research contexts for its potential influence on fat metabolism, muscle physiology, cognitive function, and metabolic regulation. Ongoing studies continue to examine its effects on lipid metabolism, insulin sensitivity, and broader endocrine signaling pathways.

For Research Use Only. Not intended for human consumption.